E-6005 clinical trials
Also written E6005.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How each study uses E-6005 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses E-6005 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedPhase 1/2Organon and CoNCT01179880Written as E6005
- A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic DermatitisCompletedPhase 1/2Organon and CoNCT02094235Written as E6005 0.05%
- A Phase 2 Study of E6005 in Patients With Atopic DermatitisCompletedPhase 2Organon and CoNCT01461941Written as E6005
- Study of RVT-501 in Adult and Adolescent Subjects With Atopic DermatitisCompletedPhase 2Dermavant Sciences GmbHNCT02950922Written as RVT-501 0.2% ointment
- Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisCompletedPhase 2Dermavant Sciences GmbHNCT03394677Written as RVT-501 0.5% ointment
- Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisStatus unknownPhase 1Dermavant Sciences GmbHNCT03415282Written as RVT-501 0.5% topical ointment
Codes
What other systems call E-6005 · ClinicalTrials.gg INT006338
- UNII (FDA) TO043KKB9CLOTAMILASTConfirmed FDA, Wikidata
- Wikidata Q27290049E-6005Confirmed FDA, Wikidata
- DrugBank DB12776One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | TO043KKB9C | LOTAMILAST | Confirmed FDA, Wikidata |
| Wikidata | Q27290049 | E-6005 | Confirmed FDA, Wikidata |
| DrugBank | DB12776 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.